In an important step, the Federal Drug Authority has pushed through an approval to get an additional dose of COVID-19 vaccines administered to the estimated 2.7 percent of adults in the United States who are immuno-compromised.
Immuno-compromised individuals, specifically solid organ transplant recipients or those diagnosed with conditions that are considered to have an equivalent level of immuno-compromise, should now be able to receive the third dose. So far, this step is restricted to people who have already received two doses of either the Pfizer-BioNTech or the Moderna COVID-19 vaccine. It is not available yet for recipients of any other vaccine, due to the lack of testing to date.
One mother’s experience of perinatal mood and anxiety disorder
When “fear of the unknown” is mentioned as a main trigger for postpartum depression and perinatal mood and anxiety disorder
Read More »